| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Puri Raj K. | Chief Regulatory Officer | C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS | /s/ Raj K. Puri | 04 Mar 2026 | 0002046483 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Common Stock | Options Exercise | +5,470 | +2.5% | $0.000000* | 221,329 | 02 Mar 2026 | Direct | F1 | |
| transaction | IOVA | Common Stock | Tax liability | -2,798 | -1.3% | $3.79* | 218,531 | 02 Mar 2026 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Restricted Stock Units | Options Exercise | -5,470 | -20% | $0.000000* | 21,878 | 02 Mar 2026 | Common stock | 5,470 | Direct | F4, F5, F6 |
| Id | Content |
|---|---|
| F1 | Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
| F2 | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. |
| F3 | Represents the common stock remaining after deducting the common stock withheld for taxes. |
| F4 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| F5 | The remaining RSUs will vest in equal quarterly installments. |
| F6 | Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |